Drug maker Roche Holding AG said over the weekend that a clinical trial for its anemia drug Cera showed it worked as well as Thousand Oaks biopharmaceutical giant Amgen's Aranesp.

Both drugs are used in patients with chronic kidney disease...

Subscribe to get the full story.

Are you a subscriber? Sign In